Acute Lymphocytic Leukemia (ALL) Recruiting Phase 2 Trials for Plerixafor (DB06809)

Back to Acute Lymphocytic Leukemia (ALL)

Also known as: Lymphocytic Leukemia, Acute / Acute Lymphocytic Leukemia / Acute Lymphoid Leukemia (ALL) / Acute Lymphatic Leukemia / Acute Lymphocytic Leukaemia / Acute Lymphoid Leukemia / Acute lymphoblastic leukemia with failed remission / Acute lymphoblastic leukaemia / Leukemia lymphoblastic acute / Acute lymphoblastic leukemia / Lymphoid leukaemia, acute / Acute lymphoid leukaemia / Lymphoid leukemia, acute / ALL / Leukaemia lymphoblastic acute / Acute lymphatic leukaemia / Leukaemias acute lymphocytic

Indication	Status	Phase
DBCOND0030518 (Acute Lymphocytic Leukemia (ALL))	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02605460	Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission	Treatment	Busulfan (DB01008) Cyclophosphamide (DB00531) Plerixafor (DB06809)